Aug 2, 2021 Cerecor Announces Drawdown of $10 Million Tranche under its Debt Financing Agreement with Horizon Technology Finance
Jul 26, 2021 Cerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease Patients
Jun 23, 2021 Cerecor Licenses Immune Checkpoint Program from Sanford Burnham Prebys Further Expanding Pipeline of Immunology and Immuno-oncology Targets
May 11, 2021 FDA Grants Fast Track Designation to CERC-002 for Treatment of Hospitalized Patients with COVID-19
